SB Drug Discovery Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
75
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
SB Drug Discovery General Information
Description
Operator of a contract research organization intended to specialize in biochemical and cell-based screening assays. The company specializes in ion channel and receptor drug discovery research delivering cell line generation and compound screening solutions in neuroscience and other therapeutic indications, thereby helping scientists to deliver the reliable data they need to drive drug development.
Contact Information
Website
www.sbdrugdiscovery.com(Operating Subsidiary)
Corporate Office
- Telford Pavilion, Todd Campus
- West of Scotland Science Park
- Glasgow G20 0XA
- Scotland, United Kingdom
Corporate Office
- Telford Pavilion, Todd Campus
- West of Scotland Science Park
- Glasgow G20 0XA
- Scotland, United Kingdom
SB Drug Discovery Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SB Drug Discovery Comparisons
Industry
Financing
Details
SB Drug Discovery Competitors (9)
One of SB Drug Discovery’s 9 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ |
SB Drug Discovery Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SB Drug Discovery Patents
SB Drug Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201908665-D0 | Treatment of cognitive disorders | Inactive | 17-Jun-2019 | ||
| GB-201812276-D0 | Treatment of cognitive disorders | Inactive | 27-Jul-2018 | ||
| GB-201809408-D0 | Treatment of cognitive disorders | Inactive | 07-Jun-2018 | ||
| GB-0806803-D0 | Reverse reporter assay | Inactive | 15-Apr-2008 | ||
| WO-2009127872-A1 | Reverse reporter assay | Inactive | 15-Apr-2008 | C12Q1/6897 |
SB Drug Discovery Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SB Drug Discovery FAQs
-
When was SB Drug Discovery founded?
SB Drug Discovery was founded in 1994.
-
Where is SB Drug Discovery headquartered?
SB Drug Discovery is headquartered in Glasgow, United Kingdom.
-
What is the size of SB Drug Discovery?
SB Drug Discovery has 75 total employees.
-
What industry is SB Drug Discovery in?
SB Drug Discovery’s primary industry is Drug Discovery.
-
Is SB Drug Discovery a private or public company?
SB Drug Discovery is a Private company.
-
What is SB Drug Discovery’s current revenue?
The current revenue for SB Drug Discovery is .
-
Who are SB Drug Discovery’s competitors?
Volastra, Ability Pharma, Ona Therapeutics, Gesynta Pharma, and Bristol-Myers Squibb are some of the 9 competitors of SB Drug Discovery.
-
When was SB Drug Discovery acquired?
SB Drug Discovery was acquired on 17-Jan-2023.
-
Who acquired SB Drug Discovery?
SB Drug Discovery was acquired by Sygnature Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
